Antimicrobial Susceptibility Testing Market Challenging Health Concerns 2030

Antimicrobial Susceptibility Testing Market: Overview The popularity of antimicrobial susceptibility testing (AST) technologies has stemmed from the prevalence of infectious diseases that are of bacterial origin. This has propelled a steady evolution for the antimicrobial susceptibility testing (AST) market. AST is comprised of lab procedure used by medical technologists in general or clinical laboratory scientists specifically to identify the best or most suitable antimicrobial regimen for treating individual patients. AST has been found to be useful for improving the span of the current narrow-spectrum antimicrobials. Some of the key tests used are Broth dilution tests, antimicrobial gradient method, and disk diffusion tests.

Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4863

The study on the antimicrobial susceptibility testing market is an in-depth, statistical model-based assessment of key growth drivers and restraints, key challenges and winning imperatives of top incumbent players, and imminent investment pockets. The research authors aim to offer a scrutiny of current and new trends of production and consumption, and offers share and size of various key segments.

The study highlights key strategic moves made by new entrants and leading incumbent players to capture new consumer propositions with the objective to consolidate their market shares.

Antimicrobial Susceptibility Testing Market: Key Trends

Over the years, over-prescription of antimicrobials has become rampant, and is increasingly becoming a global problem. Per the European Centre for Disease Prevention and Control (ECDC), 30–50% of all antimicrobials prescribed to humans are not well supported by clinical rationale.

The trend for so long has given rise to emergence of resistant pathogens. In the current times of Covid-19, AST has become increasingly useful approach that should be a part of the larger epidemiological studies to help in infection prevention and control.

Some of isolates that are possible with AST are extended-spectrum β-lactamase producers, carbapenemase-producing Enterobacteriaceae, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci.

The role of AST in expanding the understanding of origin and spread of the disease is a key trend bolstering R&D in AST platforms.

Advancements in infrastructure of clinical microbiology laboratories in the developing world have led to adoption of semi-automated systems and manual tests. Growing application of antibiotic gradient strips has opened a new avenue in the AST market.

However, several countries still have inadequate clinical microbiology laboratories and the paucity of qualified laboratory scientists.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=4863

Antimicrobial Susceptibility Testing Market: Competitive Dynamics and Key Developments

Various healthcare settings have seen the need for instituting novel AST platforms. In this regard, advances made in phenotyping methods, and the advent of new, novel digital imaging and genomic approaches are shaping the contours of the AST market.

Development of rapid AST platforms have been riddled with numerous regulatory, legal, and technological hurdles. Companies in the AST market are facing tall challenges to move beyond the proof-of-concept phase, mandating the need for better quality control systems.

A growing number of medical equipment manufacturers are aiming to reduce the long time to result (TTR) and turnaround times of the currently available AST.

Some of the top players in the AST market are;

CONDALAB
bioMérieux SA
Roche Diagnostics Limited
Bio-Rad Laboratories, Inc.
Danaher Corporation,
Thermo Fisher Scientific
Becton, Dickinson, and Company.
Antimicrobial Susceptibility Testing Market: Regional Assessment

On the regional front, North America and Europe have presented several lucrative revenue streams to industry stakeholders in the global antimicrobial susceptibility testing (AST) market. Companies in Europe are relentlessly working to unveil rapid AST platforms.

The regional market has also witnessed active participation of European Committee of Antimicrobial Susceptibility Testing (EUCAST) in development and implementation of these technologies so that the major shortcomings are addressed.

Read Comprehensive Overview of Report @ https://www.tmrresearch.com/antimicrobial-susceptibility-testing-market

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.